Examkin

Question

Difficulty: Very hardNeonatal Disorders

A 38-week-gestation male neonate is born to a 28-year-old G2P1 mother with blood type O, Rh-negative. The mother did not receive prenatal care or anti-D immune globulin during her pregnancy. At 8 hours of life, the infant becomes progressively lethargic and is noted to have significant scleral icterus and jaundice extending to the lower abdomen. A transcutaneous bilirubin measurement is markedly elevated above the 95th percentile for his age in hours. Arrange the following diagnostic and therapeutic steps in the most appropriate escalating chronological sequence for the management of this patient's condition.

  1. 1Obtain serum fractionated bilirubin, direct antiglobulin test (DAT), and reticulocyte count
  2. 2Initiate continuous intensive phototherapy
  3. 3Administer intravenous immunoglobulin (IVIG)
  4. 4Place umbilical venous and arterial catheters
  5. 5Perform a double-volume exchange transfusion

Answer

The correct escalating sequence is: 1) Obtain confirmatory labs (serum bilirubin, DAT, reticulocyte count), 2) Initiate intensive phototherapy, 3) Administer IVIG, 4) Place umbilical vascular catheters, and 5) Perform a double-volume exchange transfusion.
The correct sequence reflects the standard algorithmic escalation of care for severe neonatal isoimmune hyperbilirubinemia. Immediate confirmatory laboratory testing is essential for any pathologic jaundice appearing in the first 24 hours of life. Intensive phototherapy is the cornerstone first-line intervention. If bilirubin levels continue to rise rapidly in the setting of confirmed immune-mediated hemolysis (such as Rh incompatibility), IVIG is administered to halt ongoing red blood cell destruction. When these temporizing measures fail and bilirubin nears the threshold for acute bilirubin encephalopathy, securing central access via umbilical catheters is urgently required to perform a definitive double-volume exchange transfusion.

Step-by-Step Solution

1
Recognize early-onset pathologic jaundice and obtain diagnostic laboratories.
Serum fractionated bilirubin, DAT, and reticulocyte count are drawn.
Visible jaundice presenting within the first 24 hours of life is always considered pathologic and carries a high risk of kernicterus. Serum confirmation and etiology identification (DAT for immune hemolysis) are mandatory first steps.
2
Initiate first-line non-invasive therapy.
Continuous intensive phototherapy is started.
Phototherapy rapidly converts neurotoxic unconjugated bilirubin into excretable isomers (lumirubin) and must be started immediately in severe cases while awaiting diagnostic lab results.
3
Administer targeted medical therapy for immune hemolysis.
IVIG is given.
In the setting of Rh isoimmunization, if bilirubin rises rapidly or approaches exchange transfusion thresholds despite intensive phototherapy, IVIG is administered to decrease hemolysis by blocking reticuloendothelial Fc receptors.
4
Prepare for definitive invasive therapy.
Umbilical venous and arterial catheters are placed.
When medical management fails to halt the bilirubin rise, central access is required to safely and effectively perform a double-volume exchange transfusion.
5
Execute definitive emergency therapy.
A double-volume exchange transfusion is performed.
This is the final step in the algorithmic escalation, used only when bilirubin reaches critical thresholds, directly removing circulating bilirubin and antibody-coated red blood cells to prevent permanent neurological damage.

Key Concept

The stepwise escalation of management in severe neonatal isoimmune hemolytic disease (e.g., Rh incompatibility), progressing from diagnostic confirmation to phototherapy, IVIG, and ultimately exchange transfusion.
Rate this question

Topics

Neonatal Disorders

More questions from this topic